Literature DB >> 12615957

International Union of Pharmacology. XXXV. The glucagon receptor family.

Kelly E Mayo1, Laurence J Miller, Dominique Bataille, Stéphane Dalle, Burkhard Göke, Bernard Thorens, Daniel J Drucker.   

Abstract

Peptide hormones within the secretin-glucagon family are expressed in endocrine cells of the pancreas and gastrointestinal epithelium and in specialized neurons in the brain, and subserve multiple biological functions, including regulation of growth, nutrient intake, and transit within the gut, and digestion, energy absorption, and energy assimilation. Glucagon, glucagon-like peptide-1, glucagon-like peptide-2, glucose-dependent insulinotropic peptide, growth hormone-releasing hormone and secretin are structurally related peptides that exert their actions through unique members of a structurally related G protein-coupled receptor class 2 family. This review discusses advances in our understanding of how these peptides exert their biological activities, with a focus on the biological actions and structural features of the cognate receptors. The receptors have been named after their parent and only physiologically relevant ligand, in line with the recommendations of the International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615957     DOI: 10.1124/pr.55.1.6

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  139 in total

1.  The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.

Authors:  R J Mann; N E Nasr; J K Sinfield; E Paci; D Donnelly
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 3.  Current insights and new perspectives on the roles of hyperglucagonemia in non-insulin-dependent type 2 diabetes.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

4.  Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: comparison of intravenous and intramuscular drug administration.

Authors:  Andreas Gutzeit; Christoph A Binkert; Dow-Mu Koh; Klaus Hergan; Constantin von Weymarn; Nicole Graf; Michael A Patak; Justus E Roos; Marcus Horstmann; Sebastian Kos; Simone Hungerbühler; Johannes M Froehlich
Journal:  Eur Radiol       Date:  2012-01-22       Impact factor: 5.315

5.  Glucagon receptor-mediated extracellular signal-regulated kinase 1/2 phosphorylation in rat mesangial cells: role of protein kinase A and phospholipase C.

Authors:  Xiao C Li; Oscar A Carretero; Yuan Shao; Jia L Zhuo
Journal:  Hypertension       Date:  2006-01-03       Impact factor: 10.190

Review 6.  The role of gut hormones in glucose homeostasis.

Authors:  Daniel J Drucker
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

7.  Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse.

Authors:  Bernardo Yusta; Dianne Matthews; Jacqueline A Koehler; Gemma Pujadas; Kiran Deep Kaur; Daniel J Drucker
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

8.  Molecular cloning and characterization of two pig vasoactive intestinal polypeptide receptors (VPAC1-R and VPAC2-R).

Authors:  Xiaping He; Fengyan Meng; Yajun Wang; Juan Li
Journal:  DNA Cell Biol       Date:  2014-02-12       Impact factor: 3.311

9.  Glucagon receptor gene mutations with hyperglucagonemia but without the glucagonoma syndrome.

Authors:  Helen C Miller; Mark Kidd; Irvin M Modlin; Patrizia Cohen; Roberto Dina; Panagiotis Drymousis; Panagiotis Vlavianos; Günter Klöppel; Andrea Frilling
Journal:  World J Gastrointest Surg       Date:  2015-04-27

10.  Vagal afferent fibres determine the oxytocin-induced modulation of gastric tone.

Authors:  Gregory M Holmes; Kirsteen N Browning; Tanja Babic; Samuel R Fortna; F Holly Coleman; R Alberto Travagli
Journal:  J Physiol       Date:  2013-04-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.